Yin Yan sold $455k of BIOE
Chief Executive Officer at Bio Essence Corp. 323,845 shares at an average of $1.41, traded Oct 28, 2024, filed Nov 18, 2024.
Score components
- +25RoleCEO
- +17Trade size$455k at market
- +20Share of holdings soldSold 67% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +29.0%, 3m +34.9%, 6m -15.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-24-099693, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 28, 2024 | SOpen-market sale Common Stock | -140,000 | $2.48 | $347k | 345,859 | Nov 18, 2024 |
| Oct 29, 2024 | SOpen-market sale Common Stock | -40,000 | $0.64 | $26k | 2,561 | Nov 18, 2024 |
| Oct 30, 2024 | SOpen-market sale Common Stock | -143,845 | $0.57 | $82k | 82,124 | Nov 18, 2024 |
Related signals
Other insiders at Bio Essence Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | BIOEbuy Bio Essence Corp | Yin Yan Chief Executive Officer | $2.5M 5,000,000 shares | +56% | |
| 56Moderate | BIOEbuy Bio Essence Corp | Yin Yan Chief Executive Officer | $2.5M 5,000,000 shares | +36% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.